Revenue Nearly Doubled YoY
Revenue jumped 91.4% year-over-year from $662M to $1.267B in Q2 2026, a scale of growth that strongly suggests a transformative acquisition rather than organic expansion, as organic growth at this magnitude would be extraordinary for an analytical instruments company.
Profitability Reversed to a Loss
Operating income swung from a positive $152M in Q2 2025 to a loss of -$47M in Q2 2026 (a -130.9% decline), while net income fell from $121M to -$72M (-159.5%), indicating that acquisition-related costs, amortization, and integration expenses are significantly weighing on earnings.
SG&A and R&D Costs Surged Dramatically
SG&A expenses rose 122.4% YoY to $387M and R&D expenses increased 104.3% to $96M, both growing faster than revenue, reflecting the cost structure absorbed from an acquired business and elevated integration spending that compressed margins.